INTRODUCTION
Adverse drug reactions (ADR) are an unintended and harmful effect resulting from the use of medications intended for diagnostic, therapeutic, or preventative reasons 1, 2) . Adverse drug reactions are frequent and expensive causes of mortality and morbidity that appear to be increasing in patients of all ages. Adverse drug reactions in neonates are related to the immature metabolism process, and its prevalence in neonates is estimated to be three times that in adults [3] [4] [5] . Adverse drug reactions increase dramatically when more than four different drugs are administered 1) . Among high-risk newborns admitted to of the cases, the infant experiences more than one adverse drug reaction 6, 7) . The metabolism of medications in neonates varies according to the postnatal age and gestational age, because it is related to the transportation of drug substances from the mother to the infant through the placenta or milk and immaturity of the organs. The immaturity of the liver and kidneys affects drug metabolism 8, 9) . Thus, it is inappropriate to apply information regarding drug metabolism in adults or children directly to newborns. However, few drugs have been studied with regard to their effects on newborns. In particular, up to 55% to 80% of drugs in current use in NICU are unlicensed or off-label drugs due to the lack of clinical data, and >50% of all prescriptions are unlicensed or off-label drugs. Approximately 80% to 97% of all high-risk newborns admitted to a neonatal intensive care unit are prescribed >1 unlicensed or off-label drug 10) . These problems cause dilemmas for the clinicians responsible for prescribing medication. However, to date, to the best of our knowledge, there is no Korean study that has reported adverse drug reactions occurring in a neonatal intensive care unit.
Thus, the present study was conducted to analyze and report the findings of adverse drug reactions in a single neonatal intensive care unit.
MATERIALS AND METHODS

Subjects
The study was retrospectively conducted using medical records of infants admitted to the neonatal intensive care unit in Dong-A University Hospital between August 1, 2013 and July 31, 2014. The subjects were patients who were reported to the regional drug monitoring center by the doctor or nurse in charge of adverse reactions that were most likely related to drugs administered during hospital treatment. The varying symptoms caused by a single drug, as well as single symptoms caused by various drugs, were defined in isolated reports.
Methods
The analysis of causality between the drug and adverse reaction was jointly conducted by a neonatologist, a pharmacist specializing in adverse drug reactions, and an internist specializing in drug allergies at the regional drug monitoring center.
The cases were evaluated according to Naranjo's scale 11) , the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) standard 2) , and the Korean adverse drug reaction algorithm 12) . The scores on Naranjo's scale were classified into 4 stages of definite, probable, possible, and doubtful. The stages in the WHO-UMC standard were certain, probable or likely, possible, unlikely, conditional or unclassified, unassessable or unclassifiable. The Korean algorithm had the following 4 stages of classifications: certain, probable, possible, and unlikely.
Statistics
The data were expressed as the number of patients, cases, and percentages using descriptive statistics. Values are shown as averages±standard deviation.
RESULTS
Characteristics of the study patients
Of the 410 patients admitted to the neonatal intensive care, 40 patients experienced adverse drug reactions, thereby exhi biting a 9.8% incidence. The average gestation age of the study subjects was 28.6±4.3 weeks, the average birth weight was 1,184±622 g, and adverse drug reactions occurred at an average of 21±30 days after birth. The total number of prescriptions during the study period was 43,641 cases with 57 reported cases of adverse drug reactions, showing an incidence of 0.13%.
Adverse drug reaction symptoms and causative agents
Magnesium sulfate was the number one causative drug with 21 cases (36.8%), and among these, the most frequent cases occurred in which the mothers had been administered the drug (n=12 cases, 21.1%), the remaining 9 cases were associated with the maintenance dose (0.5 mEq/kg) in total parenteral nutrition, with all cases showing hypermagnesemia (serum magnesium >2.8 mg/dL). A total of 8 cases (14.0%), attributed to respira tory drugs (aminophylline and theophylline), showed tachy cardia (heart rate >180/min) with an increased serum drug level (>15 ug/mL). Total parenteral nutrition was attributed to 7 cases (12.3%) with cholestasis (direct bilirubin >2.0 mg/dL) reported in all of the patients. Six cases (10.5%) were attributed to lipid emulsion (triglycerides >200 mg/dL). Four cases (7%) were traced to an antibiotic with all of the cases were
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Neonatal Med 2015 November;22(4):187-191 http://dx.doi.org/10.5385/nm.2015. 22.4.187 attributed to the same drug (vancomycin), and increases in serum creatinine (>1.5 mg/dL), oliguria (urine output <1.0 mL/ Kg/hr), and serum drug level (through level >10 ug/mL) were reported. Nonsteroidal anti-inflammatory drugs (NSAIDs, ibuprofen), reported in 4 cases (7.0%), were prescribed in all of the cases to treat patent ductus arteriosus where the related sign were oliguria, thrombocytopenia (<60,000/mm 3 ), increas ed serum creatinine, and gastrointestinal bleeding. Four cases (7.0 %) of phenobarbital use showed decreased activity, oxygen desaturation and an increased serum drug level (>40 ug/mL). Two (3.5%) cases were related to Synagis with oxygen desaturation and apnea, whereas the antiviral agent ganciclovir was related to 1 case (1.8%) with skin rashes (Table 1) .
Results of adverse drug reaction evaluation
When the adverse drug reaction causality of the 57 cases were tested according to Naranjo's scale, there were 0 definite cases (0%), 42 probable cases (73.7%), 13 possible cases (22.8%), and 2 doubtful cases (3.5%), with the majority being categorized as "probable" cases. Evaluation using the WHO-UMC standard resulted in 1 certain case (1.8%), 12 probable or likely cases (21.1%), 41 possible cases (71.9%), 1 unlikely case (1.8%), 0 conditional or unclassified cases, and 2 unassessable or unclassifiable cases (3.5%), with the majority categorized as "possible" cases. According to the Korean algorithm, 2 cases were certain (3.5%), 30 (52.6%) were probable or likely, 23 (40.4%) were possible, and 2 (3.5%) were unlikely, with the majority being categorized as "probable or likely. " Fifty-five (96.5%) of the 57 reported cases were classified as meaningful i.e., having more than a possible likelihood of causality in all of the 3 tests 13) ( Table 2) .
DISCUSSION
Adverse drug reactions in neonates related with increased mortality and morbidity 14, 15) . Adverse drug reactions in newborns are related to their immature drug metabolism systems and occur three times more often than in adult cases 3) . The following points should be considered to understand drug metabolism disadvantages in neonates 8) . First, because drug metabolism can vary widely depending on the postnatal age or gestational age, some drugs that can be dangerous at high serum level (aminophylline, digoxin, aminoglycoside, and anti- .
In the result of this study, 33 cases of total 57 cases were associated with the increased serum drug level at the therapeutic drug monitoring. Second, because gastrointestinal blood flow and muscle blood flow are impaired until sufficient post birth adjustment, drug absorption from the digestive system and muscles is insufficient and unstable, requiring intravenous administration of necessary medications 16) . Third, the plasma protein levels, especially albumin, are low, resulting in increased free fractions of drug substances and indicating that a lower blood concentration is sufficient to reach effective concentration levels 17) . care. Twelfth, neonates can be affected by drugs administered to the mother through the placenta and milk 16) . 19, 20) , but lower than 30% of high-risk neonates experiencing adverse drug reactions among neonatal intensive care unit (NICU) patients 6, 7) . This result may be attributed to a lower proportion of cases suspected of adverse drug reactions and was reported as such. The majority of adverse drug reactions were reported by nurses directly in charge of patient care
at the time this study was conducted by doctors. Thus, active interest on the part of all medical staff, including nurses is required. According to the reported adverse drug reactions, the largest number of cases was caused by magnesium sulfate administered to the mother 21) , demonstrating the unique characteristics of neonatal drug metabolism reactions. In this study, magnesium sulfate was administrated at 17.6±29.3 hours before the delivery time due to the pregnancy induced hyper tension, and the administrated dose was 21.1±23.2 g. Moreover, this finding is distinct from that observed in adult cases, in which skin symptoms are most frequent, and in children, in whom vaccine-related incidents occur most frequently 22, 23) , 
